Cardinal Health | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 64.01 B

Revenue: As of FY2026 Q1, the actual value is USD 64.01 B, beating the estimate of USD 59.27 B.

EPS: As of FY2026 Q1, the actual value is USD 1.88, beating the estimate of USD 1.7882.

EBIT: As of FY2026 Q1, the actual value is USD 678 M.

Revenue

• Total revenue increased by 22% to $64 billion in Q1 FY26 from $52.3 billion in Q1 FY25.

Operating Earnings

• GAAP operating earnings increased by 18% to $668 million in Q1 FY26 from $568 million in Q1 FY25.
• Non-GAAP operating earnings increased by 37% to $857 million in Q1 FY26 from $625 million in Q1 FY25.

Net Earnings

• Net earnings attributable to Cardinal Health, Inc. increased by 8% to $450 million in Q1 FY26 from $416 million in Q1 FY25.
• Non-GAAP net earnings attributable to Cardinal Health, Inc. increased by 33% to $611 million in Q1 FY26 from $460 million in Q1 FY25.

Effective Tax Rate

• GAAP effective tax rate was 24.1% in Q1 FY26 compared to 23.0% in Q1 FY25.
• Non-GAAP effective tax rate was 21.9% in Q1 FY26 compared to 23.0% in Q1 FY25.

Diluted EPS

• GAAP diluted EPS increased by 11% to $1.88 in Q1 FY26 from $1.70 in Q1 FY25.
• Non-GAAP diluted EPS increased by 36% to $2.55 in Q1 FY26 from $1.88 in Q1 FY25.

Segment Results

Pharmaceutical and Specialty Solutions

• Revenue increased by 23% to $59.2 billion in Q1 FY26 from $48.0 billion in Q1 FY25.
• Segment profit increased by 26% to $667 million in Q1 FY26 from $530 million in Q1 FY25.

Global Medical Products and Distribution

• Revenue increased by 2% to $3.2 billion in Q1 FY26 from $3.1 billion in Q1 FY25.
• Segment profit increased to $46 million in Q1 FY26 from $8 million in Q1 FY25.

Other

• Revenue increased by 38% to $1.6 billion in Q1 FY26 from $1.2 billion in Q1 FY25.
• Segment profit increased by 60% to $166 million in Q1 FY26 from $104 million in Q1 FY25.

Cash Flow

• Net cash provided by operating activities was $973 million in Q1 FY26 compared to - $1,647 million in Q1 FY25.
• Non-GAAP adjusted free cash flow was $1,269 million in Q1 FY26 compared to - $1,361 million in Q1 FY25.

Outlook / Guidance

• Cardinal Health raised its fiscal year 2026 non-GAAP EPS guidance to $9.65 to $9.85 and non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billion.
• The company anticipates completing the acquisition of Solaris Health in early November.
• Updated guidance reflects increased expectations at the segment level, with Pharmaceutical and Specialty Solutions segment profit growth raised to 16% to 19% and Other segment profit growth raised to 29% to 31%.